Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections

Eur Respir J. 2017 May 21;49(5):1700083. doi: 10.1183/13993003.00083-2017. Print 2017 May.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Diarylquinolines / administration & dosage*
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Mycobacterium abscessus

Substances

  • Anti-Bacterial Agents
  • Diarylquinolines
  • bedaquiline